A-319, a CD3xCD19 T cell engager, monotherapy for patients with refractory/relapsed B-cell acute lymphoblastic leukemia (r/r B-ALL)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Jin Wang, Yong Guo, Qike Zhang, Youfan Feng, Junyuan Qi, Xuejun Zhang, Li Wang, Rui Huang, Runhui Zheng, Xing Zhao, Xuanfan Zhong, Shengjie Xue, Wuzhong Shen, Ying Tan, Guojian Yu, Guiyun Tu, Hanyang Chen, Jason Xu, Cheng Huang, Xiao Qiang Yan, Jian-Qing Mi, Ting Liu
Institutions: Shanghai Jiao Tong University, Ruijin Hospital, Sichuan University, West China Hospital of Sichuan University, Gansu Provincial Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Zhujiang Hospital, Southern Medical University, Guangzhou Medical University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016237
Cites:
Cited by:
Related to: